A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer

Clinical Oncology : a Journal of the Royal College of Radiologists
V SrinivasanA G Turner

Abstract

Pain and haematuria are two of the most distressing symptoms in patients with advanced bladder cancer. The aim of palliative radiotherapy is to relieve these symptoms with the minimum of stress to the patient and with minimal side effects. Two treatment regimens were studied: hypofractionated radiotherapy giving 1700 cGy in two fractions over 3 days and conventional palliative radiotherapy giving 4500 cGy in 12 fractions over 26 days. This study assesses 41 patients, all with Grade II-III T3-4 transitional cell carcinomas of the bladder treated between 1982 and 1989, presenting with haematuria and local pain. Two-fraction (hypofractionated) treatment was given to 22 patients and conventional palliative radiotherapy to 19; patients were selected by performance status. The effect on haematuria was assessed as cleared, intermittent or persistent. Pain was assessed by noting reduction in the need for opiate analgesia. Any side effect was recorded. In the patients receiving two-fraction radiotherapy, 59% had clearance of the haematuria and in 73% there was improvement of their pain, compared with 16% and 37% respectively in those receiving conventional palliation. Survival of the two groups was 9.77 months and 14.47 months respectiv...Continue Reading

References

Jan 1, 1970·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·J Dutreix, A Wambersie

❮ Previous
Next ❯

Citations

Sep 1, 1995·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·B M BiswalB K Mohanti
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A Y RostomW F White
Jul 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L SengeløvH von der Maase
May 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D B McLarenM D Mason
Jun 2, 1998·International Journal of Radiation Oncology, Biology, Physics·J CervekM Zumer-Pregelj
Feb 14, 2002·Critical Reviews in Oncology/hematology·Filippo de BraudCora N Sternberg
Mar 14, 2003·Critical Reviews in Oncology/hematology·Vittorio DonatoAlfredo Zurlo
Oct 26, 1999·Critical Reviews in Oncology/hematology·C N Sternberg
Mar 27, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Perry W GrigsbyJ F Williamson
Jun 26, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·R HuddartE Hall
Mar 23, 2011·The Surgical Clinics of North America·Jennifer N WuChristopher P Evans
Apr 13, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·Jing YanW Levin
Sep 8, 2005·The Journal of Urology·Joon-Ha OkChristopher P Evans
Feb 15, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Luc van Lonkhuijzen, Gillian Thomas
Jan 25, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·E LacarrièreP Grise
Mar 3, 2007·Cancer·Stephen T LutzAndre A Konski
Oct 5, 2010·The Cancer Journal·Stephen LutzBenjamin Corn
Apr 29, 1998·The Journal of Small Animal Practice·W Bredal, I Vollset
Apr 24, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Julia Hippisley-Cox, Carol Coupland
Oct 13, 2004·The Oncologist·Jose Pereira, Tien Phan
Dec 21, 2018·BMJ Case Reports·Senthil SundaravadananPhilip Joseph
Nov 1, 1995·Current Problems in Cancer·M Alagiri, R E Greenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.